Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A Genetically engineered cell-based system for detecting metabolism-mediated toxicity.

S Bull1, I Langezaal, R Clothier

  • 1ECVAM, Institute for Health & Consumer Protection, European Commission Joint Research Centre, 21020 Ispra (VA), Italy.

Alternatives to Laboratory Animals : ATLA
|November 16, 2001
PubMed
Summary

A new in vitro model using engineered cells reveals how cytochrome P450 (CYP450) enzymes create toxic metabolites. This tool aids in understanding chemical toxicity and identifying specific CYP450 isoforms involved in human liver metabolism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating the Boundaries of Health and Identity: Medical Students' Perspectives.

The clinical teacher·2025
Same author

Sexual Health Advocacy for Guys (SHAG): a randomized trial of the impact of a text-messaging program on HIV incidence and STI testing among a national sample of sexual minority cisgender adolescent and young adult men.

Trials·2025
Same author

A tiered assessment of human health risks associated with exposure to persistent, mobile and toxic chemicals via drinking water.

The Science of the total environment·2024
Same author

Designing a couple-based relationship strengthening and health enhancing intervention for pregnant women living with HIV and their male partners in Zambia: Interview findings from the target community.

Social science & medicine (1982)·2021
Same author

Association of a Disease Complex Involving a Begomovirus, DNA 1 and a Distinct DNA Beta with Leaf Curl Disease of Okra in Pakistan.

Plant disease·2019
Same author

Group-based patient education delivered by nurses to meet a clinical standard for glaucoma information provision: the G-TRAIN feasibility study.

Pilot and feasibility studies·2018

Area of Science:

  • Biochemistry
  • Toxicology
  • Cell Biology

Background:

  • Xenobiotics are metabolized by cytochrome P450 (CYP450) enzymes, potentially forming reactive metabolites responsible for toxicity.
  • Understanding metabolism-mediated toxicity is crucial for drug development and chemical safety assessment.

Purpose of the Study:

  • To develop and validate an in vitro model for studying direct toxicity from CYP450-mediated metabolic activation.
  • To assess the role of specific CYP450 isoforms in the bioactivation of xenobiotics and subsequent cytotoxicity.

Main Methods:

  • Utilized genetically engineered NIH-3T3 and V79 cell lines expressing specific human or rat CYP450 isoforms.
  • Exposed cell lines to model compounds (1,3-dichloropropanol, cyclophosphamide) and assessed cytotoxicity using neutral red uptake and Alamar Blue reduction assays.

Related Experiment Videos

  • Employed specific inhibitors to confirm CYP450-isoform dependency of reactive metabolite formation.

    • Main Results:

    • Cell lines expressing CYP450 enzymes exhibited increased toxicity upon exposure to test compounds compared to control cells.
    • Cytotoxicity was directly linked to the formation of CYP450-generated metabolites.
    • Inhibition studies confirmed that the bioactivation pathway and resulting toxicity were dependent on specific CYP450 isoforms.

    Conclusions:

    • The developed in vitro model effectively demonstrates CYP450-mediated bioactivation and subsequent toxicity.
    • This model provides a valuable tool for identifying metabolic capabilities and determining the role of specific CYP450 isoforms in xenobiotic toxicity.
    • The findings support the use of engineered cell panels for predicting human liver metabolism-mediated toxicity.